Vonderheide RH, Flaherty KT, Khalil M: Clinical Activity and Immune Modulation in Cancer Patients Treated with CP-870,893, A Novel CD40) Agonist Monoclonal Antibody. J Clin Oncol. 8 (25): 876-83,2007.
Vonderheide R: CD40 Antibody for the Treatment of Advanced Solid Tumors (Phase I Study). University of Pennsylvania Department of Hematology-Oncology : 2006.
Domcheck S: CTLA4 Antibody in the Treatment of Advanced Breast Cancer (Phase I Study). University of Pennsylvania Department of Hematology-Oncology : 2006.
Stumacher M: Update on chemoprevention in BRCA1 and BRCA2 mutation carriers. Breast Cancer Online 8 (9): 2005.
Weeks J, Joffe S: The Use of Executive Summaries in Cancer Patients' Consent to Clinical Trial Enrollment (Phase II study). Dana Farber Cancer Institute : 2003.